Role of cholesterol in synapse formation and function

Biochimica et Biophysica Acta - Biomembranes

Volumn 1610, Issue 2, 2003, Pages 271-280

  Pfrieger, Frank W ^a  

^a CENTRE DE NEUROCHIMIE   (France)

Author keywords

Astrocyte; Lipid raft; Lipoprotein; Neurodegenerative disease; Synaptic vesicle; Synaptogenesis

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STEROID HORMONE;

ASTROCYTE; BIOAVAILABILITY; CELL CULTURE; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DENDRITE; EXOCYTOSIS; GLIA; HYPOTHESIS; MEMBRANE STRUCTURE; MOLECULAR MIMICRY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRECURSOR; PRIORITY JOURNAL; RAFT DOMAIN; RETINA GANGLION CELL; REVIEW; SYNAPSE; SYNAPSE VESICLE; SYNAPTIC POTENTIAL; SYNAPTOGENESIS;

MAMMALIA;

EID: 0037429703     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(03)00024-5     Document Type: Review

References (154)

1. Gibbons G.F., Mitropoulos K.A., Myant N.B. Biochemistry of Cholesterol. 1982;Elsevier, Amsterdam.
2. Yeagle P.L. Cholesterol and the cell membrane. Biochim. Biophys. Acta. 822:1985;267-287.
3. Mann R.K., Beachy P.A. Cholesterol modification of proteins. Biochim. Biophys. Acta. 1529:2000;188-202.
4. Farese R.V., Herz J. Cholesterol metabolism and embryogenesis. Trends Genet. 14:1998;115-120.
5. Moebius F.F., Fitzky B.U., Glossmann H. Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol. Metab. 11:2000;106-114.
6. Roux C., Wolf C., Mulliez N., Gaoua W., Cormier V., Chevy F., Citadelle D. Role of cholesterol in embryonic development. Am. J. Clin. Nutr. 71:2000;1270S-1279S.
7. Kelley R.I., Herman G.E. Inborn errors of sterol biosynthesis. Annu. Rev. Genomics Hum. Genet. 2:2001;299-341.
8. Nwokoro N.A., Wassif C.A., Porter F.D. Genetic disorders of cholesterol biosynthesis in mice and humans. Mol. Genet. Metab. 74:2001;105-119.
9. Sacks F.M. Why cholesterol as a central theme in coronary artery disease? Am. J. Cardiol. 82:1998;14T-17T.
10. McNamara D.J. Dietary cholesterol and atherosclerosis. Biochim. Biophys. Acta. 1529:2000;310-320.
11. Opitz J.M., Gilbert-Barness E., Ackerman J., Lowichik A. Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions. Pediatr. Pathol. Mol. Med. 21:2002;153-181.
12. Vanier M.T. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem. Res. 24:1999;481-489.
13. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids. 34:1999;225-234.
14. Baulieu E.E., Robel P., Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46:2001;1-32.
15. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12:2001;105-112.
16. Schmitz G., Orso E. Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells. Neurochem. Res. 26:2001;1045-1068.
17. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur. J. Endocrinol. 145:2001;669-679.
18. Mellon S.H., Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13:2002;35-43.
19. Strittmatter W.J., Bova H.C. Molecular biology of apolipoprotein E. Curr. Opin. Lipidol. 13:2002;119-123.
20. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:2001;1354-1357.
21. Göritz C., Mauch D.H., Nägler K., Pfrieger F.W. Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse-glia affair. J. Physiol. (Paris). 96:2002;257-263.
22. Pfrieger F.W. The role of glia in the development of synaptic contacts. Volterra A., Magistretti P.J., Haydon P.G. Tripartite Synapses: Synaptic Transmission with Glia. 2002;24-34 Oxford Univ. Press, Oxford. Chapter 2.
23. Pfrieger F.W. Role of glia in synapse development. Curr. Opin. Neurobiol. 12:2002;486-490.
24. Pfrieger F.W. Outsourcing in the brain: Do neurons depend on cholesterol delivery by astrocytes? BioEssays. 25:2003;72-78.
25. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by glial cells. Science. 277:1997;1684-1687.
26. Nägler K., Mauch D.H., Pfrieger F.W. Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J. Physiol. 533:2001;665-679.
27. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science. 291:2001;657-661.
28. Jacobson M. Developmental Neurobiology. 1991;Plenum, New York.
29. Pfrieger F.W., Barres B.A. New views on synapse-glia interactions. Curr. Opin. Neurobiol. 6:1996;615-621.
30. Barres B.A., Silverstein B.E., Corey D.P., Chun L.L.Y. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1:1988;791-803.
31. Meyer-Franke A., Kaplan M.R., Pfrieger F.W., Barres B.A. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron. 15:1995;805-819.
32. Spector A.A., Yorek M.A. Membrane lipid composition and cellular function. J. Lipid Res. 26:1985;1015-1035.
33. Yeagle P.L. Lipid regulation of cell membrane structure and function. FASEB J. 3:1989;1833-1842.
34. Barrantes F.J. Structural-functional correlates of the nicotinic acetylcholine receptor and its lipid microenvironment. FASEB J. 7:1993;1460-1467.
35. Bastiaanse E.M., Hold K.M., Van der L.A. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc. Res. 33:1997;272-283.
36. Burger K., Gimpl G., Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57:2000;1577-1592.
37. Jones D.G. Synapses and Synaptosomes: Morphological Aspects. 1975;Chapman & Hall, London.
38. Whittaker V.P. 30 years of synaptosome research. J. Neurocytol. 22:1993;735-742.
39. Whittaker V.P. Some properties of synaptic membranes isolated from the central nervous system. Ann. N.Y. Acad. Sci. 137:1966;982-998.
40. Lapetina E.G., Soto E.F., De Robertis E. Lipids and proteolipids in isolated subcellular membranes of rat brain cortex. J. Neurochem. 15:1968;437-445.
41. Cotman C., Blank M.L., Moehl A., Snyder F. Lipid composition of synaptic plasma membranes isolated from rat brain by zonal centrifugation. Biochemistry. 8:1969;4606-4612.
42. Simon R.G., Gill M., Lemkey-Johnston N., Larramendi L.M. Cholesterol and phospholipid composition of cerebellar fractions enriched in unmyelinated axons and synaptosomes. Exp. Brain Res. 13:1971;504-513.
43. Kornguth S.E., Flangas A.L., Geison R.L., Scott G. Morphology, isopycnic density and lipid content of synaptic complexes isolated from developing cerebellums and different brain regions. Brain Res. 37:1972;53-68.
44. Hitzemann R.J., Johnson D.A. Developmental changes in synaptic membrane lipid composition and fluidity. Neurochem. Res. 8:1983;121-131.
45. Igarashi M., Waki H., Hirota M., Hirabayashi Y., Obata K., Ando S. Differences in lipid composition between isolated growth cones from the forebrain and those from the brainstem in the fetal rat. Brain Res., Dev. Brain Res. 51:1990;1-9.
46. Wood W.G., Strong R., Williamson L.S., Wise R.W. Changes in lipid composition of cortical synaptosomes from different age groups of mice. Life Sci. 35:1984;1947-1952.
47. Eckert G.P., Wood W.G., Muller W.E. Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes. J. Neural Transm. 108:2001;1051-1064.
48. Johnson R.C., McKean C.M., Shah S.N. Fatty acid composition of lipids in cerebral myelin and synaptosomes in phenylketonuria and Down syndrome. Arch. Neurol. 34:1977;288-294.
49. Wood W.G., Schroeder F., Hogy L., Rao A.M., Nemecz G. Asymmetric distribution of a fluorescent sterol in synaptic plasma membranes: effects of chronic ethanol consumption. Biochim. Biophys. Acta. 1025:1990;243-246.
50. Smith T.L. Synaptosomal cholesterol and phospholipid levels in several mouse strains differentially sensitive to ethanol. J. Pharmacol. Exp. Ther. 232:1985;702-707.
51. Igbavboa U., Avdulov N.A., Schroeder F., Wood W.G. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J. Neurochem. 66:1996;1717-1725.
52. Igbavboa U., Avdulov N.A., Chochina S.V., Wood W.G. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J. Neurochem. 69:1997;1661-1667.
53. Hayashi H., Igbavboa U., Hamanaka H., Kobayashi M., Fujita S.C., Wood W.G., Yanagisawa K. Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. NeuroReport. 13:2002;383-386.
54. Raggers R.J., Pomorski T., Holthuis J.C., Kalin N., van Meer G. Lipid traffic: the ABC of transbilayer movement. Traffic. 1:2000;226-234.
55. Liscum L., Munn N.J. Intracellular cholesterol transport. Biochim. Biophys. Acta. 1438:1999;19-37.
56. Loura L.M., Fedorov A., Prieto M. Exclusion of a cholesterol analog from the cholesterol-rich phase in model membranes. Biochim. Biophys. Acta. 1511:2001;236-243.
57. Papaphilis A., Deliconstantinos G. Modulation of serotonergic receptors by exogenous cholesterol in the dog synaptosomal plasma membrane. Biochem. Pharmacol. 29:1980;3325-3327.
58. Shapiro H.K., Barchi R.L. Alteration of synaptosomal plasma membrane cholesterol content: membrane physical properties and cation transport proteins. J. Neurochem. 36:1981;1813-1818.
59. North P., Fleischer S. Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. Effect on gamma-aminobutyric acid uptake. J. Biol. Chem. 258:1983;1242-1253.
60. 2+-stimulated ATPase and lipid fluidity of synaptosomal plasma membranes from dog and rabbit brain. Comp. Biochem. Physiol., B. 89:1988;585-594.
61. Maguire P.A., Druse M.J. The influence of cholesterol on synaptic fluidity, dopamine D1 binding and dopamine-stimulated adenylate cyclase. Brain Res. Bull. 23:1989;69-74.
62. Whiting K.P., Restall C.J., Brain P.F. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci. 67:2000;743-757.
63. Severs N.J., Robenek H. Detection of microdomains in biomembranes. An appraisal of recent developments in freeze-fracture cytochemistry. Biochim. Biophys. Acta. 737:1983;373-408.
64. Nakajima Y., Bridgman P.C. Absence of filipin-sterol complexes from the membranes of active zones and acetylcholine receptor aggregates at frog neuromuscular junctions. J. Cell Biol. 88:1981;453-458.
65. Ko C.P., Propst J.W. Absence of sterol-specific complexes at active zones of degenerating and regenerating frog neuromuscular junctions. J. Neurocytol. 15:1986;231-240.
66. Cooper N.G., McLaughlin B.J. The distribution of filipin-sterol complexes in photoreceptor synaptic membranes. J. Comp. Neurol. 230:1984;437-443.
67. Perrelet A., Garcia-Segura L.M., Singh A., Orgi L. Distribution of cytochemically detectable cholesterol in the electric organ of Torpedo marmorata. Proc. Natl. Acad. Sci. U. S. A. 79:1982;2598-2602.
68. Renau-Piqueras J., Miragall F., Marques A., Baguena-Cervellera R., Guerri C. Chronic ethanol consumption affects filipin-cholesterol complexes and intramembranous particles of synaptosomes of rat brain cortex. Alcohol Clin. Exp. Res. 11:1987;486-493.
69. Surchev L., Dontchev V., Ichev K., Dolapchieva S., Bozhilova-Pastirova A., Vankova M., Kirazov E., Vassileva E., Venkov L. Changes in the neuronal plasma membrane during synaptogenesis. Cell Mol. Biol. (Noisy-le-grand). 41:1995;1073-1080.
70. Egea G., Marsal J., Solsona C., Rabasseda X., Blasi J. Increase in reactive cholesterol in the presynaptic membrane of depolarized Torpedo synaptosomes: blockade by botulinum toxin type A. Neuroscience. 31:1989;521-527.
71. Miller R.G. The use and abuse of filipin to localize cholesterol in membranes. Cell Biol., Int. Rep. 8:1984;519-535.
72. Lang T., Bruns D., Wenzel D., Riedel D., Holroyd P., Thiele C., Jahn R. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J. 20:2001;2202-2213.
73. Chamberlain L.H., Burgoyne R.D., Gould G.W. SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5619-5624.
74. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
75. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:1998;111-136.
76. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1:2000;31-39.
77. Ikonen E. Roles of lipid rafts in membrane transport. Curr. Opin. Cell Biol. 13:2001;470-477.
78. Kurzchalia T.V., Parton R.G. Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11:1999;424-431.
79. Zimmermann H. Biochemistry of the isolated cholinergic vesicle. Klein R.L., Lagercrantz H., Zimmermann H. Neurotransmitter Vesicles. 1982;271-304 Academic Press, London.
80. Breckenridge W.C., Morgan I.G., Zanetta J.P., Vincendon G. Adult rat brain synaptic vesicles: II. Lipid composition. Biochim. Biophys. Acta. 320:1973;681-686.
81. Nagy A., Baker R.R., Morris S.J., Whittaker V.P. The preparation and characterization of synaptic vesicles of high purity. Brain Res. 109:1976;285-309.
82. Wagner J.A., Carlson S.S., Kelly R.B. Chemical and physical characterization of cholinergic synaptic vesicles. Biochemistry. 17:1978;1199-1206.
83. Deutsch J.W., Kelly R.B. Lipids of synaptic vesicles: relevance to the mechanism of membrane fusion. Biochemistry. 20:1981;378-385.
84. DeVries G.H., Zetusky W.J., Zmachinski C., Calabrese V.P. Lipid composition of axolemma-enriched fractions from human brains. J. Lipid Res. 22:1981;208-216.
85. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature. 407:2000;189-194.
86. Huttner W.B., Zimmerberg J. Implications of lipid microdomains for membrane curvature, budding and fission. Curr. Opin. Cell Biol. 13:2001;478-484.
87. Haque M.E., McIntosh T.J., Lentz B.R. Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles: "nature's own" fusogenic lipid bilayer. Biochemistry. 40:2001;4340-4348.
88. Hannah M.J., Schmidt A.A., Huttner W.B. Synaptic vesicle biogenesis. Annu. Rev. Cell Dev. Biol. 15:1999;733-798.
89. Thiele C., Hannah M.J., Fahrenholz F., Huttner W.B. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol. 2:2000;42-49.
90. Martin T.F. Racing lipid rafts for synaptic-vesicle formation. Nat. Cell Biol. 2:2000;E9-E11.
91. Klopfenstein D.R., Tomishige M., Stuurman N., Vale R.D. Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor. Cell. 109:2002;347-358.
92. Garner C.C., Nash J., Huganir R.L. PDZ domains in synapse assembly and signalling. Trends Cell Biol. 10:2000;274-280.
93. Kennedy M.B. Signal-processing machines at the postsynaptic density. Science. 290:2000;750-754.
94. Sheng M., Pak D.T. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu. Rev. Physiol. 62:2000;755-778.
95. Bruses J.L., Chauvet N., Rutishauser U. Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J. Neurosci. 21:2001;504-512.
96. Suzuki T., Ito J., Takagi H., Saitoh F., Nawa H., Shimizu H. Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res., Mol. Brain Res. 89:2001;20-28.
97. Perez A.S., Bredt D.S. The N-terminal PDZ-containing region of postsynaptic density-95 mediates association with caveolar-like lipid domains. Neurosci. Lett. 258:1998;121-123.
98. Bruckner K., Pablo L.J., Scheiffele P., Herb A., Seeburg P.H., Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron. 22:1999;511-524.
99. Becher A., White J.H., McIlhinney R.A. The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J. Neurochem. 79:2001;787-795.
100. Fallon L., Moreau F., Croft B.G., Labib N., Gu W.J., Fon E.A. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277:2002;486-491.
101. Bromley S.K., Burack W.R., Johnson K.G., Somersalo K., Sims T.N., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. Annu. Rev. Immunol. 19:2001;375-396.
102. Khan A.A., Bose C., Yam L.S., Soloski M.J., Rupp F. Physiological regulation of the immunological synapse by agrin. Science. 292:2001;1681-1686.
103. Sanes J.R., Lichtman J.W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev., Neurosci. 2:2001;791-805.
104. Meier J., Vannier C., Serge A., Triller A., Choquet D. Fast and reversible trapping of surface glycine receptors by gephyrin. Nat. Neurosci. 4:2001;253-260.
105. Borgdorff A.J., Choquet D. Regulation of AMPA receptor lateral movements. Nature. 417:2002;649-653.
106. Popot J.L., Demel R.A., Sobel A., van Deenen L.L., Changeux J.P. Interaction of the acetylcholine (nicotinic) receptor protein from Torpedo marmorata electric organ with monolayers of pure lipids. Eur. J. Biochem. 85:1978;27-42.
107. Schiebler W., Hucho F. Membranes rich in acetylcholine receptor: characterization and reconstitution to excitable membranes from exogenous lipids. Eur. J. Biochem. 85:1978;55-63.
108. Leibel W.S., Firestone L.L., Legler D.C., Braswell L.M., Miller K.W. Two pools of cholesterol in acetylcholine receptor-rich membranes from Torpedo. Biochim. Biophys. Acta. 897:1987;249-260.
109. Jones O.T., McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 27:1988;2364-2374.
110. Zacharias D.A., Violin J.D., Newton A.C., Tsien R.Y. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 296:2002;913-916.
111. Lichtman J.W., Colman H. Synapse elimination and indelible memory. Neuron. 25:2000;269-278.
112. Buttiglione M., Revest J.M., Pavlou O., Karagogeos D., Furley A., Rougon G., Faivre-Sarrailh C. A functional interaction between the neuronal adhesion molecules TAG-1 and F3 modulates neurite outgrowth and fasciculation of cerebellar granule cells. J. Neurosci. 18:1998;6853-6870.
113. Lang D.M., Lommel S., Jung M., Ankerhold R., Petrausch B., Laessing U., Wiechers M.F., Plattner H., Stuermer C.A. Identification of reggie-1 and reggie-2 as plasma membrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J. Neurobiol. 37:1998;502-523.
114. He Q., Meiri K.F. Isolation and characterization of detergent-resistant microdomains responsive to NCAM-mediated signaling from growth cones. Mol. Cell. Neurosci. 19:2002;18-31.
115. Niethammer P., Delling M., Sytnyk V., Dityatev A., Fukami K., Schachner M. Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. J. Cell Biol. 157:2002;521-532.
116. Leitinger B., Hogg N. The involvement of lipid rafts in the regulation of integrin function. J. Cell Sci. 115:2002;963-972.
117. Crossin K.L., Krushel L.A. Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev. Dyn. 218:2000;260-279.
118. Angst B.D., Marcozzi C., Magee A.I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 114:2001;629-641.
119. Tsui-Pierchala B.A., Encinas M., Milbrandt J., Johnson E.M. Jr. Lipid rafts in neuronal signaling and function. Trends Neurosci. 25:2002;412-417.
120. Biederer T., Sara Y., Mozhayeva M., Atasoy D., Liu X., Kavalali E.T., Sudhof T.C. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science. 297:2002;1525-1531.
121. de Chaves E.I., Rusinol A.E., Vance D.E., Campenot R.B., Vance J.E. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272:1997;30766-30773.
122. Michikawa M., Yanagisawa K. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J. Neurochem. 72:1999;2278-2285.
123. Fan Q.W., Yu W., Senda T., Yanagisawa K., Michikawa M. Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. J. Neurochem. 76:2001;391-400.
124. Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R., Ibanez C.F. Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron. 29:2001;171-184.
125. Henderson L.P., Lin L., Prasad A., Paul C.A., Chang T.Y., Maue R.A. Embryonic striatal neurons from Niemann-Pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J. Biol. Chem. 275:2000;20179-20187.
126. Frenzel K.E., Falls D.L. Neuregulin-1 proteins in rat brain and transfected cells are localized to lipid rafts. J. Neurochem. 77:2001;1-12.
127. Lynch C., Mobley W. Comprehensive theory of Alzheimer's disease. The effects of cholesterol on membrane receptor trafficking. Ann. N.Y. Acad. Sci. 924:2000;104-111.
128. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., Gu J., Rosenfeld M.A., Pavan W.J., Krizman D.B., Nagle J., Polymeropoulos M.H., Sturley S.L., Ioannou Y.A., Higgins M.E., Comly M., Cooney A., Brown A., Kaneski C.R., Blanchette-Mackie E.J., Dwyer N.K., Neufeld E.B., Chang T.Y., Liscum L., Strauss J.F. III, Ohno K., Zeigler M., Carmi R., Sokol J., Markie D., O'Neill R.R., van Diggelen O.P., Elleder M., Patterson M.C., Brady R.O., Vanier M.T., Pentchev P.G., Tagle D.A. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 277:1997;228-231.
129. Loftus S.K., Morris J.A., Carstea E.D., Gu J.Z., Cummings C., Brown A., Ellison J., Ohno K., Rosenfeld M.A., Tagle D.A., Pentchev P.G., Pavan W.J. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277:1997;232-235.
130. Lassmann H. Patterns of synaptic and nerve cell pathology in Alzheimer's disease. Behav. Brain Res. 78:1996;9-14.
131. Beffert U., Danik M., Krzywkowski P., Ramassamy C., Berrada F., Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res. Rev. 27:1998;119-142.
132. George-Hyslop P.H. Molecular genetics of Alzheimer's disease. Biol. Psychiatry. 47:2000;183-199.
133. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
134. Richard F., Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur. J. Pharmacol. 412:2001;1-12.
135. Michikawa M., Fan Q.W., Isobe I., Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 74:2000;1008-1016.
136. Gong J.S., Kobayashi M., Hayashi H., Zou K., Sawamura N., Fujita S.C., Yanagisawa K., Michikawa M. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 277:2002;29919-29926.
137. Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. N.Y. Acad. Sci. 924:2000;81-90.
138. Hartmann T. Cholesterol, A beta and Alzheimer's disease. Trends Neurosci. 24:2001;S45-S48.
139. Koudinova N.V., Koudinov A.R., Yavin E. Alzheimer's Abeta1-40 peptide modulates lipid synthesis in neuronal cultures and intact rat fetal brain under normoxic and oxidative stress conditions. Neurochem. Res. 25:2000;653-660.
140. Michikawa M., Gong J.S., Fan Q.W., Sawamura N., Yanagisawa K. A novel action of Alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release. J. Neurosci. 21:2001;7226-7235.
141. Chochina S.V., Avdulov N.A., Igbavboa U., Cleary J.P., O'Hare E.O., Wood W.G. Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 42:2001;1292-1297.
142. Bodovitz S., Klein W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271:1996;4436-4440.
143. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6460-6464.
144. Frears E.R., Stephens D.J., Walters C.E., Davies H., Austen B.M. The role of cholesterol in the biosynthesis of beta-amyloid. NeuroReport. 10:1999;1699-1705.
145. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5815-5820.
146. Ji S.R., Wu Y., Sui S.F. Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277:2002;6273-6279.
147. Runz H., Rietdorf J., Tomic I., de Bernard M., Beyreuther K., Pepperkok R., Hartmann T. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci. 22:2002;1679-1689.
148. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., Duff K.E. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8:2001;890-899.
149. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T. Jr., Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4:1998;730-734.
150. Riddell D.R., Christie G., Hussain I., Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11:2001;1288-1293.
151. Wahrle S., Das P., Nyborg A.C., McLendon C., Shoji M., Kawarabayashi T., Younkin L.H., Younkin S.G., Golde T.E. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9:2002;11-23.
152. Sipione S., Rigamonti D., Valenza M., Zuccato C., Conti L., Pritchard J., Kooperberg C., Olson J.M., Cattaneo E. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum. Mol. Genet. 11:2002;1953-1965.
153. Cummings C.J., Zoghbi H.Y. Trinucleotide repeats: mechanisms and pathophysiology. Annu. Rev. Genomics Hum. Genet. 1:2000;281-328.
154. Orr H.T. Beyond the Qs in the polyglutamine diseases. Genes Dev. 15:2001;925-932.